Iovance Biotherapeutics Inc.
IOVA | NASDAQ
$10.39
+$0.20 (+1.96%)
Sep 22, 2026, 11:50 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -2.50 | -5.78 | -4.30 | -2.57 | -8.56 | -24.68 |
PEG Ratio | 0.17 | 0.18 | 0.18 | -0.22 | -0.46 | -0.97 |
PS Ratio | 3.70 | 13.07 | 1.61K | n/a | n/a | n/a |
PB Ratio | 1.40 | 3.02 | 3.27 | 2.04 | 4.71 | 9.77 |
P/FCF Ratio | -2.90 | -5.89 | -4.98 | -3.25 | -11.03 | -25.47 |
P/OCF Ratio | -3.23 | -6.08 | -5.28 | -3.48 | -12.85 | -31.28 |
OCF/S Ratio | -114.77 | -215.14 | -30.43K | n/a | n/a | n/a |
Debt / Equity Ratio | 0.07 | 0.08 | 0.13 | 0.17 | 0.12 | 0.08 |
Quick Ratio | 2.83 | 3.31 | 2.70 | 5.24 | 5.69 | 11.59 |
Current Ratio | 3.20 | 3.74 | 2.79 | 5.24 | 5.69 | 11.59 |
Asset Turnover | 0.29 | 0.18 | 0 | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | -133.63 | n/a | n/a |
Return on Equity | -55.97% | -52.39% | -75.95% | -79.24% | -55.05% | -39.54% |
Return on Assets | -42.82% | -40.88% | -56.90% | -59.62% | -44.03% | -33.78% |
Return on Invested Capital | -51.52% | -48.98% | -67.42% | -68.17% | -49.44% | -36.39% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 97.23% | 24.43% | -804.54% | n/a | n/a | n/a |
Net Profit Margin | -148.38% | -226.84% | -37.35K% | n/a | n/a | n/a |
Pretax Profit Margin | -149.16% | -228.56% | -37.64K% | n/a | n/a | n/a |
Operating Profit Margin | -153.08% | -240.92% | -38.73K% | n/a | n/a | n/a |
FCF Margin | -127.61% | -221.88% | -32.31K% | n/a | n/a | n/a |
EBITDA Margin | -135.52% | -201.99% | -34.85K% | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove IOVA